They’re tiny drug-delivery systems 1000 times smaller than a human hair, but while nanomedicines have long been hailed as the future for treating debilitating and life-threatening diseases, their journey from lab to patient has many challenges.
New DELIVER guidelines aim to accelerate nanomedicine development
- Post author:
- Post published:September 6, 2024
- Post category:uncategorized